Business Context and Reporting Period
Company: ScanSource, Inc. (SCSC)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal Year ended June 30, 2026
Business Overview: ScanSource is a leading technology distributor serving approximately 25,000 channel sales partners in the United States and Brazil. The company operates two segments: Specialty Technology Solutions (wholesale/resale of hardware, SaaS, and connectivity) and Intelisys & Advisory (agency model for connectivity and cloud services). Key suppliers include Cisco and Zebra Technologies, each accounting for over 10% of net sales.
Key Financial Metrics
| Metric | Fiscal 2026 | Fiscal 2025 |
|---|---|---|
| Net Sales | $3.23 billion | $3.04 billion |
| Gross Profit | $437.4 million | $408.6 million |
| Gross Margin | 13.6% | 13.4% |
| Operating Income | $98.6 million | $85.2 million |
| Operating Margin | 3.1% | 2.8% |
| Net Income | $78.9 million | $71.5 million |
| Diluted EPS | $3.64 | $3.00 |
| Adjusted EBITDA (Non-GAAP) | $151.5 million | $144.7 million |
| Cash from Operations | $123.1 million | $112.3 million |
| Cash and Equivalents (End of Period) | $88.4 million | $126.2 million |
| Total Debt | $101.4 million | $136.1 million |
| Share Repurchases | $97.5 million (2.4M shares) | $106.5 million (2.5M shares) |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 6.1% year-over-year, driven by a 6.2% increase in the Specialty Technology Solutions segment and a 3.1% increase in Intelisys & Advisory. Organic growth (constant currency, excluding acquisitions) was 5.2%.
- Profitability: Operating income rose 15.8% to $98.6 million. Gross margin expanded 20 basis points to 13.6%, aided by favorable supplier program recognition in the Specialty segment, partially offset by higher freight costs.
- Expense Management: Restructuring and other charges decreased significantly by 67.2% to $1.8 million. Depreciation and intangible amortization expenses also declined due to assets becoming fully depreciated.
- Geographic Performance: U.S. sales grew 7.1%, while International sales (primarily Brazil) declined 5.6% due to foreign exchange headwinds and market conditions.
- Balance Sheet: Total debt decreased by approximately $35 million as the company repaid prior credit facilities and entered a new credit agreement. Cash balances declined by $37.8 million, primarily due to share repurchases and working capital investments.
Guidance, Outlook, and Risks
- Capital Allocation: The company continues to prioritize share repurchases, with approximately $120.8 million remaining under current authorizations. Capital expenditures for fiscal 2027 are expected to range from $8.0 million to $12.0 million.
- Recent Acquisition: On August 20, 2026, ScanSource announced an agreement to acquire MicroAge for $220.5 million in cash, expected to close in Q1 fiscal 2027. This aims to expand capabilities in cloud, cybersecurity, and AI.
- Macroeconomic Risks: Management cites uncertainty regarding tariffs, inflation, and geopolitical tensions. While the U.S. Supreme Court invalidated certain tariffs in early 2026, new tariffs remain in effect, potentially impacting supply chains and costs.
- Cybersecurity: The company experienced a ransomware attack in May 2023. While operations were restored, the company notes ongoing risks and has incurred restoration costs. Insurance recoveries related to this event were recorded in prior periods.
- Supplier Concentration: Significant reliance on Cisco and Zebra (each >10% of sales) poses a risk if agreements are terminated or terms change, as contracts are generally short-term and terminable on notice.
Investor Verification Checklist
- Supplier Concentration: Verify the stability of distribution agreements with Cisco and Zebra, given their combined impact on over 20% of revenue and the short-term nature of contracts.
- MicroAge Acquisition: Monitor the closing of the $220.5 million MicroAge acquisition and its impact on leverage ratios and integration costs.
- Working Capital Trends: Review Days Sales Outstanding (DSO), which increased to 73 days from 70 days, and inventory turnover to assess liquidity efficiency.
- Foreign Exchange Exposure: Assess the impact of the Brazilian Real on international sales, which declined 12.7% on a constant currency basis.
- Debt Covenants: Confirm continued compliance with the new credit facility covenants (Leverage Ratio ≤ 3.50x, Interest Coverage Ratio ≥ 3.00x).